MarketsStocksAPLLTD
AP

Alembic Pharmaceuticals Ltd

NSE: APLLTDBSE: 533573Healthcare
Download Research Report7-page PDF
746.15
+1.05%
NSE · auto-updates while market open
Prev Close
₹987.60
Day High
₹754.15
Day Low
₹732.65
Mkt Cap
₹14,821 Cr
P / E
22.1
P / B
2.6
ROE
12.3%
52W High
₹1,107.90
52W Low
₹635.80
Key Metrics
Market Cap
₹14,821 Cr
P / E
22.09
P / B
2.62
EV / EBITDA
14.90
ROCE
11.7%
ROE
12.3%
Debt / Equity
0.24
Book Value
₹288.72
EPS
₹34.33
Div Yield
1.5%
Face Value
₹2
Promoter Holding
69.7%
Revenue · ₹ Cr
4.6k
FY20
5.4k
FY21
5.3k
FY22
5.7k
FY23
6.2k
FY24
6.7k
FY25
7.3k
FY26
Net Profit · ₹ Cr
801
FY20
1.1k
FY21
521
FY22
342
FY23
616
FY24
582
FY25
671
FY26
EPS · ₹ per share
₹44.0
FY20
₹60.8
FY21
₹27.8
FY22
₹17.4
FY23
₹31.3
FY24
₹29.7
FY25
₹34.3
FY26
P / E Ratio · price ÷ TTM EPS
1025395469320-5Jun 21Feb 23Oct 24Jun 26
P/E 21.7×Median 29.3×TTM EPS
Q1 2026 snapshot
Sales
₹1.87K Cr
Operating profit
-
OPM
-
Net profit
₹202 Cr
EPS
₹10.31
Scorecard · 7 axes
Quality
Avg
59/100
Valuation
Good
22.1×
Growth
Avg
+7.5%
Profitability
Avg
12.0%
Performance
Bad
-24.1%
Entry Point
Good
67%
Red Flags
Strong
0 flags
Shareholding Pattern
69.7%Promoter
Promoter69.7%
FII4.3%
DII16.2%
Public9.8%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1,692.7431,783.831,717.221,917.061,891.811,873.22
Net Profit137.695156.63153.63183.71131.95201.54
NPM %8.1%8.8%8.9%9.6%7.0%10.8%
AlertPre-trade